{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:26:01Z","timestamp":1775100361608,"version":"3.50.1"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Diabetes is a metabolic disease that can affect people at any age. Despite being one of the leading causes of death, the treatment of diabetes is extremely difficult. For the treatment of diabetes mellitus various synthetic oral hypoglycemic drugs and insulin is available. However, insulin cannot be taken orally and the synthetic agents used can have harmful side effects. Bioactive peptides are particular protein fragments that have a beneficial impact on human health and physiological processes. These peptides can be applied as antidiabetic agents in the treatment of diabetes. The aim of the current study was to develop hypoglycemic peptides (HGPs) from plant sources and to investigate their binding interactions with selected diabetic protein receptors using peptide-protein docking, in order to identify potential peptide candidates for the treatment of diabetes mellitus. The binding patterns of top seven hypoglycemic peptides with ten selected receptor proteins were explored using peptide-protein docking. The peptides P2 and P6 showed best haddock scores and binding pattern against target receptors. The P2 showed strong interactions with maltase-glucoamylase (binding energy of \u2212108.7\u2009+\u2009\/- 9.3 kcal\/mol and with six hydrogen bonds), glucose transporter 1 (GLUT1) (binding energy of \u221285.3\u2009+\u2009\/- 1.4 kcal\/mol and with three hydrogen bonds). Peptide 6 exhibited highest score against insulin-like growth factor 1 receptor (binding energy of \u2212107.5\u2009+\u2009\/- 5.4 kcal\/mol and with seven hydrogen bonds) and pancreatic alpha-amylase (binding energy of \u2212121.3\u2009+\u2009\/- 3.1 kcal\/mol and with seven hydrogen bonds), while against Jun N-terminal kinase1 receptor peptide, the peptides P5 and P6 showed same haddock energy of \u221292.1\u2009+\u2009\/- 4.1 kcal\/mol having different number of hydrogen bond interactions in both complexes. The molecular dynamics simulation revealed that P6 and P2 were firmly bound to insulin-like growth factor 1 receptor and maltase-glucoamylase, respectively for the simulation time of 100 ns. The findings of this computational study support the data showing that these hypoglycemic peptides are effective against selected diabetic proteins. The insulin-mimetic antidiabetic peptides would be integrated into active packaging systems for the development of multi-functional materials to regulate glucose absorption. However, further assessment and validation of the particular peptides as potential therapeutic candidates for diabetes mellitus are required.<\/jats:p>","DOI":"10.1371\/journal.pone.0330341","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T17:33:13Z","timestamp":1755624793000},"page":"e0330341","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterization of multi-targeted insulin-mimetic antidiabetic peptides using in silico approaches"],"prefix":"10.1371","volume":"20","author":[{"given":"Anas","family":"Bilal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-6496","authenticated-orcid":true,"given":"Ghulam","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"pone.0330341.ref001","doi-asserted-by":"crossref","first-page":"5561129","DOI":"10.1155\/2021\/5561129","article-title":"Molecular docking and simulation studies of antidiabetic agents devised from hypoglycemic polypeptide-P of momordica charantia","volume":"2021","author":"R Arif","year":"2021","journal-title":"Biomed Res Int"},{"key":"pone.0330341.ref002","unstructured":"Votey SR, Peters AL. Diabetes mellitus, type 2 - A review. 2005 [Accessed 2006 December 5]."},{"key":"pone.0330341.ref003","doi-asserted-by":"crossref","unstructured":"Piero M, Nzaro G, Njagi J. Diabetes mellitus-a devastating metabolic disorder. 2015.","DOI":"10.15272\/ajbps.v4i40.645"},{"key":"pone.0330341.ref004","first-page":"1","article-title":"Classification, pathophysiology, diagnosis and management of diabetes mellitus","volume":"6","author":"H Baynes","year":"2015","journal-title":"J diabetes metab"},{"issue":"2","key":"pone.0330341.ref005","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10989-019-09899-z","article-title":"Plant-derived bioactive peptides: a treatment to cure diabetes","volume":"26","author":"SP Patil","year":"2020","journal-title":"Int J Pept Res Ther"},{"issue":"2","key":"pone.0330341.ref006","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1089-3261(03)00020-5","article-title":"Hepatotoxicity of the thiazolidinediones","volume":"7","author":"KG Tolman","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"2","key":"pone.0330341.ref007","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.foodchem.2008.04.006","article-title":"Purification and characterisation of a hypoglycemic peptide from Momordica Charantia L. Var. abbreviata Ser","volume":"111","author":"X Yuan","year":"2008","journal-title":"Food Chem"},{"key":"pone.0330341.ref008","doi-asserted-by":"crossref","first-page":"167684","DOI":"10.1093\/ecam\/neq004","article-title":"Antidiabetic Activities of Abutilon indicum (L.) sweet are mediated by enhancement of adipocyte differentiation and activation of the GLUT1 promoter","volume":"2011","author":"C Krisanapun","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"pone.0330341.ref009","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4103\/0975-7406.90103","article-title":"Alternative therapies useful in the management of diabetes: a systematic review","volume":"3","author":"A Pandey","year":"2011","journal-title":"J Pharm Bioallied Sci"},{"issue":"2","key":"pone.0330341.ref010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.copbio.2007.01.013","article-title":"Food-derived peptides with biological activity: from research to food applications","volume":"18","author":"R Hartmann","year":"2007","journal-title":"Curr Opin Biotechnol"},{"issue":"16","key":"pone.0330341.ref011","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.3390\/molecules27165133","article-title":"Computer-aided screening of phytoconstituents from ocimum tenuiflorum against diabetes mellitus targeting DPP4 inhibition: a combination of molecular docking, molecular dynamics, and pharmacokinetics approaches","volume":"27","author":"H Sajal","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"pone.0330341.ref012","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.idairyj.2005.10.012","article-title":"Bioactive peptides: production and functionality","volume":"16","author":"H Korhonen","year":"2006","journal-title":"Int Dairy J"},{"key":"pone.0330341.ref013","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.fbp.2016.02.003","article-title":"Bioprocess challenges to the isolation and purification of bioactive peptides","volume":"98","author":"D Agyei","year":"2016","journal-title":"Food Bioproducts Process"},{"issue":"9","key":"pone.0330341.ref014","doi-asserted-by":"crossref","first-page":"908","DOI":"10.6026\/97320630019908","article-title":"PhytoSelectDBT: a database for the molecular models of anti-diabetic targets docked with bioactive peptides from selected ethno-medicinal plants","volume":"19","author":"S Roy","year":"2023","journal-title":"Bioinformation"},{"key":"pone.0330341.ref015","doi-asserted-by":"crossref","first-page":"1276444","DOI":"10.3389\/fphar.2023.1276444","article-title":"Design of a multi-target focused library for antidiabetic targets using a comprehensive set of chemical transformation rules","volume":"14","author":"FI Sald\u00edvar-Gonz\u00e1lez","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"pone.0330341.ref016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40203-020-00065-8","article-title":"In silico analysis of a potential antidiabetic phytochemical erythrin against therapeutic targets of diabetes","volume":"9","author":"MMV Rao","year":"2021","journal-title":"In Silico Pharmacol"},{"issue":"7","key":"pone.0330341.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288260","article-title":"In vitro and in silico studies for the identification of anti-cancer and antibacterial peptides from camel milk protein hydrolysates","volume":"18","author":"MJ Taghipour","year":"2023","journal-title":"PLoS One"},{"issue":"9","key":"pone.0330341.ref018","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Open Source Drug Discovery Consortium","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"pone.0330341.ref019","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/ct500592m","article-title":"Improved PEP-FOLD approach for peptide and miniprotein structure prediction","volume":"10","author":"Y Shen","year":"2014","journal-title":"J Chem Theory Comput"},{"key":"pone.0330341.ref020","doi-asserted-by":"crossref","first-page":"5550180","DOI":"10.1155\/2021\/5550180","article-title":"Investigation of hypoglycemic peptides derived from conserved regions of adMc1 to reveal their antidiabetic activities","volume":"2021","author":"HS Mahrosh","year":"2021","journal-title":"Biomed Res Int"},{"key":"pone.0330341.ref021","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"RV Honorato","year":"2024","journal-title":"Nature Protocols"},{"key":"pone.0330341.ref022","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool","volume":"40","author":"WL DeLano","year":"2002","journal-title":"CCP4 Newsl Protein Crystallogr"},{"key":"pone.0330341.ref023","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkn860","article-title":"PDBsum new things","volume":"37","author":"RA Laskowski","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"pone.0330341.ref024","doi-asserted-by":"crossref","first-page":"1077814","DOI":"10.1155\/2022\/1077814","article-title":"Investigation of plant antimicrobial peptides against selected pathogenic bacterial species using a peptide-protein docking approach","volume":"2022","author":"G Mustafa","year":"2022","journal-title":"Biomed Res Int"},{"issue":"5","key":"pone.0330341.ref025","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field","volume":"6","author":"D Shivakumar","year":"2010","journal-title":"J Chem Theory Comput"},{"key":"pone.0330341.ref026","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3390\/ani13142281","article-title":"In silico analysis of honey bee peptides as potential inhibitors of Capripoxvirus DNA-directed RNA polymerase","volume":"13","author":"G Mustafa","year":"2023","journal-title":"Animals"},{"issue":"2","key":"pone.0330341.ref027","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/ijms24021282","article-title":"Recent advances in protein-protein interactions","volume":"24","author":"IA Sedov","year":"2023","journal-title":"Int J Mol Sci"},{"key":"pone.0330341.ref028","first-page":"147648","article-title":"Protein-protein interaction detection: methods and analysis","volume":"2014","author":"VS Rao","year":"2014","journal-title":"Int J Proteomics"},{"issue":"11","key":"pone.0330341.ref029","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/nar\/gkl412","article-title":"Information-driven protein-DNA docking using HADDOCK: it is a matter of flexibility","volume":"34","author":"M van Dijk","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"pone.0330341.ref030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fmolb.2016.00046","article-title":"dMM-PBSA: a new HADDOCK scoring function for protein-peptide docking","volume":"3","author":"D Spiliotopoulos","year":"2016","journal-title":"Front Mol Biosci"},{"key":"pone.0330341.ref031","first-page":"1","article-title":"Alpha-amylase inhibition can treat diabetes mellitus","volume":"5","author":"P Agarwal","year":"2016","journal-title":"Res Rev J Med Health Sci"},{"issue":"4","key":"pone.0330341.ref032","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cbdd.13909","article-title":"Alpha-amylase as molecular target for treatment of diabetes mellitus: a comprehensive review","volume":"98","author":"N Kaur","year":"2021","journal-title":"Chem Biol Drug Des"},{"issue":"10","key":"pone.0330341.ref033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140113","article-title":"Gedunin and azadiradione: human pancreatic alpha-amylase inhibiting limonoids from neem (Azadirachta indica) as anti-diabetic agents","volume":"10","author":"S Ponnusamy","year":"2015","journal-title":"PLoS One"},{"key":"pone.0330341.ref034","doi-asserted-by":"crossref","first-page":"101154","DOI":"10.1016\/j.fbio.2021.101154","article-title":"GCMS profiling and in silico screening of alpha-amylase inhibitors in traditional pigmented rice varieties (Oryza sativa Linn) of Tamil Nadu","volume":"42","author":"R Settu","year":"2021","journal-title":"Food Bioscience"},{"key":"pone.0330341.ref035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.sajb.2022.06.021","article-title":"In vitro pharmacological investigations of Oxystelma esculentum R.Br. and in silico molecular docking analysis of its leaf constituents on diabetic related target","volume":"149","author":"TF Xavier","year":"2022","journal-title":"South African J Botany"},{"issue":"1","key":"pone.0330341.ref036","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1900\/RDS.2020.16.24","article-title":"Insulin-like growth factor and its therapeutic potential for diabetes complications - mechanisms and metabolic links: a review","volume":"16","author":"B Biadgo","year":"2020","journal-title":"Rev Diabet Stud"},{"issue":"3","key":"pone.0330341.ref037","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncpendmet0427","article-title":"Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1","volume":"3","author":"D LeRoith","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"pone.0330341.ref038","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s13205-024-03955-2","article-title":"Ab initio modeling of human IRS1 protein to find novel target to dock with drug MH to mitigate T2DM diabetes by insulin signaling","volume":"14","author":"RK Singh","year":"2024","journal-title":"3 Biotech"},{"issue":"3","key":"pone.0330341.ref039","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03632","article-title":"In silico analysis of antidiabetic potential of phenolic compounds from blue corn (Zea mays L.) and black bean (Phaseolus vulgaris L.)","volume":"6","author":"K Dami\u00e1n-Medina","year":"2020","journal-title":"Heliyon"},{"issue":"7","key":"pone.0330341.ref040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12272-021-01343-5","article-title":"Aldose Reductase: a cause and a potential target for the treatment of diabetic complications","volume":"44","author":"S Thakur","year":"2021","journal-title":"Arch Pharm Res"},{"key":"pone.0330341.ref041","doi-asserted-by":"crossref","first-page":"94","DOI":"10.9734\/jpri\/2021\/v33i41B32348","article-title":"Virtual screening, molecular docking and pharmacophore modeling of phytoconstituents of flavones as aldose reductase inhibitors","author":"JP James","year":"2021","journal-title":"JPRI"},{"issue":"9","key":"pone.0330341.ref042","doi-asserted-by":"crossref","first-page":"103766","DOI":"10.1016\/j.sjbs.2023.103766","article-title":"Network pharmacology based anti-diabetic attributes of bioactive compounds from Ocimum gratissimum L. through computational approach","volume":"30","author":"RY Halayal","year":"2023","journal-title":"Saudi J Biol Sci"},{"issue":"6","key":"pone.0330341.ref043","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors","volume":"35","author":"EE Mulvihill","year":"2014","journal-title":"Endocr Rev"},{"issue":"4","key":"pone.0330341.ref044","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/0113892037287976231212104607","article-title":"An update on dipeptidyl peptidase-IV inhibiting peptides","volume":"25","author":"SA Sivaraman","year":"2024","journal-title":"Curr Protein Pept Sci"},{"key":"pone.0330341.ref045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.peptides.2014.04.018","article-title":"In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors","volume":"57","author":"AB Nongonierma","year":"2014","journal-title":"Peptides"},{"key":"pone.0330341.ref046","doi-asserted-by":"crossref","first-page":"112738","DOI":"10.1016\/j.lwt.2021.112738","article-title":"Identification and in silico study of a novel dipeptidyl peptidase IV inhibitory peptide derived from green seaweed Ulva spp. hydrolysates","volume":"154","author":"RE Cian","year":"2022","journal-title":"LWT"},{"issue":"1","key":"pone.0330341.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40203-021-00116-8","article-title":"Investigation of phytoconstituents of Enicostemma littorale as potential glucokinase activators through molecular docking for the treatment of type 2 diabetes mellitus","volume":"10","author":"A Khan","year":"2021","journal-title":"In Silico Pharmacol"},{"issue":"2","key":"pone.0330341.ref048","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/cbdd.13979","article-title":"A comprehensive review on glucokinase activators: Promising agents for the treatment of Type 2 diabetes","volume":"99","author":"R Thilagavathi","year":"2022","journal-title":"Chem Biol Drug Des"},{"issue":"5","key":"pone.0330341.ref049","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd2850","article-title":"Assessing the potential of glucokinase activators in diabetes therapy","volume":"8","author":"FM Matschinsky","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0330341.ref050","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.29294\/IJASE.5.4.2019.1085-1098","article-title":"Identification of anti-diabetic phytocompounds from Ficus racemosa and its validation through in silico molecular modeling","volume":"5","author":"T Rathinavel","year":"2019","journal-title":"Int J Adv Sci Eng"},{"issue":"4","key":"pone.0330341.ref051","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1471-4892(03)00068-7","article-title":"JNK: a new therapeutic target for diabetes","volume":"3","author":"BL Bennett","year":"2003","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"pone.0330341.ref052","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tibs.2010.04.004","article-title":"cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance","volume":"35","author":"G Sabio","year":"2010","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"pone.0330341.ref053","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1573399052952613","article-title":"Oxidative stress and the JNK pathway in diabetes","volume":"1","author":"H Kaneto","year":"2005","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"pone.0330341.ref054","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s40203-020-00063-w","article-title":"In silico analysis of phytoconstituents from Tinospora cordifolia with targets related to diabetes and obesity","volume":"9","author":"BK Mandar","year":"2021","journal-title":"In Silico Pharmacol"},{"key":"pone.0330341.ref055","doi-asserted-by":"crossref","first-page":"100354","DOI":"10.1016\/j.fufo.2024.100354","article-title":"Pharmacoinformatics and cellular studies of algal peptides as functional molecules to modulate type-2 diabetes markers","volume":"9","author":"R Kurniawan","year":"2024","journal-title":"Future Foods"},{"issue":"17","key":"pone.0330341.ref056","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.carres.2011.09.012","article-title":"Study of the inhibition of two human maltase-glucoamylases catalytic domains by different \u03b1-glucosidase inhibitors","volume":"346","author":"L Ren","year":"2011","journal-title":"Carbohydr Res"},{"key":"pone.0330341.ref057","doi-asserted-by":"crossref","unstructured":"Sumaryada T, Roslia A, Ambarsari L, Kartono A. Molecular docking simulation of mangostin derivatives and curcuminoid on maltase-glucoamylase target for searching anti-diabetes drug candidates. IEEE; 2016: 1\u20134.","DOI":"10.1109\/IBIOMED.2016.7869832"},{"issue":"5","key":"pone.0330341.ref058","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/catal12050522","article-title":"Exploration of the Interactions between Maltase\u2013Glucoamylase and its potential peptide inhibitors by molecular dynamics simulation","volume":"12","author":"S Guan","year":"2022","journal-title":"Catalysts"},{"key":"pone.0330341.ref059","doi-asserted-by":"crossref","first-page":"108052","DOI":"10.1016\/j.compbiolchem.2024.108052","article-title":"Mammalian maltase-glucoamylase and sucrase-isomaltase inhibitory effects of Artocarpus heterophyllus: An in vitro and in silico approach","volume":"110","author":"P Abdulhaniff","year":"2024","journal-title":"Comput Biol Chem"},{"issue":"6","key":"pone.0330341.ref060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2004.03.012","article-title":"Peroxisome proliferator-activated receptor gamma in diabetes and metabolism","volume":"25","author":"SM Rangwala","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"pone.0330341.ref061","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MJT.0b013e3181c08081","article-title":"PPAR-gamma agonists and their role in type 2 diabetes mellitus management","volume":"17","author":"V Berm\u00fadez","year":"2010","journal-title":"Am J Ther"},{"issue":"1","key":"pone.0330341.ref062","doi-asserted-by":"crossref","DOI":"10.1080\/16583655.2024.2370107","article-title":"Novel derivatives of Costus igneus towards potentiality against diabetes mellitus receptors: ADME\/Tox profiling, computational docking, and molecular dynamics simulation study","volume":"18","author":"M Yadav","year":"2024","journal-title":"J Taibah Univ Sci"},{"issue":"2","key":"pone.0330341.ref063","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"302","author":"S Li","year":"2009","journal-title":"JAMA"},{"issue":"9353","key":"pone.0330341.ref064","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus","volume":"361","author":"J Spranger","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"pone.0330341.ref065","article-title":"In silico antidiabetic screening of borapetoside C, cordifolioside A and magnoflorine","volume":"81","author":"P Khanal","year":"2019","journal-title":"Pharm Sci"},{"issue":"2","key":"pone.0330341.ref066","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/138920207780368187","article-title":"Functional properties and genomics of glucose transporters","volume":"8","author":"F-Q Zhao","year":"2007","journal-title":"Curr Genomics"},{"issue":"3","key":"pone.0330341.ref067","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/jomfp.JOMFP_22_18","article-title":"Glucose transporter 1 in health and disease","volume":"23","author":"S Pragallapati","year":"2019","journal-title":"J Oral Maxillofac Pathol"},{"issue":"2","key":"pone.0330341.ref068","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jcp.24133","article-title":"Suppression of GLUT1; a new strategy to prevent diabetic complications","volume":"228","author":"L Lu","year":"2013","journal-title":"J Cell Physiol"},{"issue":"1","key":"pone.0330341.ref069","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s40200-022-00992-7","article-title":"Anti-diabetic potential of Corn silk (Stigma maydis): An in-silico approach","volume":"21","author":"RK Chaudhary","year":"2022","journal-title":"J Diabetes Metab Disord"},{"key":"pone.0330341.ref070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtbi.2015.12.004","article-title":"In-silico analysis of gymnemagenin from Gymnema sylvestre (Retz.) R.Br. with targets related to diabetes","volume":"391","author":"PK Rathore","year":"2016","journal-title":"J Theor Biol"},{"issue":"2","key":"pone.0330341.ref071","first-page":"77","article-title":"Identification of Lead Compounds against Scm (fms10) in Enterococcus faecium Using Computer Aided Drug Designing","volume":"11","author":"MA Rasheed","year":"2021","journal-title":"Life (Basel)"},{"issue":"5","key":"pone.0330341.ref072","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/md19050253","article-title":"Compounds identified from marine mangrove plant (Avicennia alba) as potential antiviral drug candidates against WDSV, an In-Silico approach","volume":"19","author":"MO Aljahdali","year":"2021","journal-title":"Mar Drugs"},{"key":"pone.0330341.ref073","doi-asserted-by":"crossref","unstructured":"Shah A, Ahmad I, Ahmad I, Amin A, Rather MA. Gene characterization, molecular docking and dynamic simulations of insulin-like growth factor receptor (IGF-1Ra) in common carp, Cyprinus carpio. Springer; 2023: 382\u201396.","DOI":"10.1007\/s12595-023-00488-z"},{"issue":"5","key":"pone.0330341.ref074","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/1389203720666191119095624","article-title":"Therapeutic potential of medicinal plant proteins: present status and future perspectives","volume":"21","author":"SS Wani","year":"2020","journal-title":"Curr Protein Pept Sci"},{"issue":"6","key":"pone.0330341.ref075","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/foods12061327","article-title":"Novel Plant-Protein (Quinoa) derived bioactive peptides with potential anti-hypercholesterolemic activities: identification, characterization and molecular docking of bioactive peptides","volume":"12","author":"FF Ajayi","year":"2023","journal-title":"Foods"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T17:33:28Z","timestamp":1755624808000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330341"}},"subtitle":[],"editor":[{"given":"Rajesh Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":75,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0330341","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}